<DOC>
	<DOCNO>NCT02422901</DOCNO>
	<brief_summary>The aim long-term observational study documentation use PASCORBIN® 7.5 g patient vitamin C deficiency . Regarding vitamin C deficiency , investigator focus acquisition data underlie disease reduction symptom , related oxidative stress vitamin-C-deficiency . Next , exact assessment medical tolerance detail treatment requirement aim . Here investigator take account acute chronic underlie medical condition . Further health economic data collect .</brief_summary>
	<brief_title>A Long-term Study Describe Use PASCORBIN® 7.5 g Patients With Vitamin C Deficiency</brief_title>
	<detailed_description>The observational study begin 01 November 2012 schedule period 10 year continue ( 01 November 2022 ) . The duration observational study patient fix corresponding character non-interventional study . According underlying disease , characterize either acute chronic , 2 3 observation within treatment period , respectively . Documentation comprise course underlying disease ( track general diseases-specific symptom ) , drug compatibility ( ADR assessment ) , concomitant medication treatment , health economic data , detail treatment regimen standard epidemiological data .</detailed_description>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Ascorbic Acid Deficiency</mesh_term>
	<mesh_term>Scurvy</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>patient vitamin C deficiency patient &gt; = 12 year old oxalate urolithiasis , iron storage disorder ( thalassemia , hemochromatosis , sideroblastic anemia ) receive recently transfuse pack red blood cell 12 year age pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>